TrialThe pharmacogenomics journal2010

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

J F Deeken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.